Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Telphase M 25 Tablet ER

Prescription Icon
Prescription Required

Marketer

Griffins Life Sciences Pvt. Ltd

Salt Composition

Telmisartan (40mg) + Metoprolol Succinate (25mg)

Overview Telphase M 25 Tablet ER

CardioPhase 25mg Extended-Release tablets manage hypertension, reducing the risk of strokes and heart attacks. Early use improves heart attack survival rates. Consistent blood levels are achieved by taking this medication with food at the same time daily, as directed by your physician. Do not discontinue use without consulting your doctor, even if feeling well, as hypertension often presents without symptoms. Maintaining a healthy lifestyle, including regular exercise, weight management, and a balanced diet, further supports blood pressure control. Common side effects may include headache, weakness, dizziness, low blood pressure, elevated potassium, occasional orthostatic hypotension (possibly with fainting), shortness of breath, nausea, vomiting, stomach pain, and tiredness. Avoid potassium-rich foods and supplements. Dizziness is possible; avoid driving and rise slowly from a seated position. Regular monitoring of blood pressure, blood sugar, kidney function, urea, and electrolytes may be necessary. Inform your doctor of any liver or kidney issues before commencing treatment. Pregnant or breastfeeding individuals should seek medical advice prior to use. Always disclose all medications, particularly those for hypertension or heart conditions.

Uses of Telphase M 25 Tablet ER

Managing Elevated Blood Pressure

Major Benefits of Telphase M 25 Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Telphase M 25 Tablet ER with a meal.

Common Side effects of Telphase M 25 Tablet ER:

  • Headache
  • Weakness
  • Dizziness
  • Cold extremities
  • Slow heart rate
  • Increased potassium level in blood
  • Decreased blood pressure
  • Orthostatic hypotension (sudden lowering of blood pressure on standing)
  • Breathlessness
  • Vomiting
  • Abdominal pain

How to use Telphase M 25 Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Telphase M 25 Tablet ER should be administered with a meal.

How Telphase M 25 Tablet ER works:

Telmisartan and Metoprolol Succinate, combined in Telphase M 25 ER tablets, provide effective blood pressure management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Telphase M 25 Tablet ER and alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Telphase M 25mg tablets pose a confirmed risk to the fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Telphase M 25mg tablets appear to pose minimal breastfeeding risk. Available human data indicate negligible infant hazard.

DrivingDrivingUNSAFE

Extended-release Telphase M 25 tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.

KidneyKidneySAFE IF PRESCRIBED

Extended-release Telphase M 25 tablets pose no safety concerns for patients with renal impairment; dose modification is unnecessary.

LiverLiverCAUTION

Extended-release Telphase M 25 tablets require careful administration in individuals with hepatic impairment. Dosage modification for Telphase M 25 extended-release tablets may be necessary. Physician consultation is advised.

What if you forget to take Telphase M 25 Tablet ER :

Should you forget a Telphase M 25 Tablet ER dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Telphase M 25 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Heart

FAQs on Telphase M 25 Tablet ER

Yes, Telphase M 25 Tablet ER Succinate may cause dizziness, especially upon standing up quickly from a lying or sitting position. To minimize this risk, stand slowly after sitting or lying down.
Improve your health by adopting a healthier lifestyle alongside Telphase M 25 Tablet ER Succinate. Quit smoking to lower your risk of heart attack and stroke. Manage your weight through diet and exercise. A balanced diet rich in fruits and vegetables, combined with regular physical activity, strengthens your heart and reduces heart attack risk.
Continue taking Telphase M 25 Tablet ER as prescribed, even if you feel healthy. Abruptly stopping this medication can cause serious problems, including heart attack and stroke.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Telphase M 25 Tablet ER
98
MRP 119
17% off